SMMT
Summit Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$16.12
+0.66 ▲ +4.27%
🌙 3월 13일 7:53 PM ET (한국 3/14 08:53)
$16.01
-0.11 ▼ -0.67%
| Index | - | P/E | - | EPS (ttm) | -1.44 | Insider Own | 86.17% | Shs Outstand | 0.78B | Perf Week | 6.68% |
| Market Cap | 12.00B | Forward P/E | - | EPS next Y | -0.93% | Insider Trans | 0.09% | Shs Float | 0.10B | Perf Month | 5.7% |
| Enterprise Value | 11.31B | PEG | - | EPS next Q | -0.25 | Inst Own | 15.86% | Short Float | 33.67% | Perf Quarter | -10.14% |
| Income | -1.08B | P/S | - | EPS this Y | 23.92% | Inst Trans | 11.89% | Short Ratio | 13.56 | Perf Half Y | -13.33% |
| Sales | 0.00B | P/B | 18.97 | EPS next 5Y | 39.43% | ROA | -181.94% | Short Interest | 34.67M | Perf YTD | -7.83% |
| Book/sh | 0.85 | P/C | 16.81 | EPS past 3/5Y | -52.45% -13.76% | ROE | -206.1% | 52W High | -56.33% ($36.91) | Perf Year | -16% |
| Cash/sh | 0.96 | P/FCF | - | Sales past 3/5Y | - | ROIC | -159.62% | 52W Low | 16.56% ($13.83) | Perf 3Y | 953.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -369.7% | Gross Margin | - | Volatility(W/M) | 5.13% 4.91% | Perf 5Y | 149.15% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.83 | Perf 10Y | 135.71% |
| Dividend Ex-Date | - | Quick Ratio | 9.87 | EPS Q/Q | -244.58% | Profit Margin | - | RSI (14) | 52.9 | Recom | 1.59 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.87 | Sales Q/Q | - | SMA20 | 2.33% ($15.75) | Beta | -1.31 | Target Price | $31.71 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2000000 | SMA50 | -0.03% ($16.12) | Rel Volume | 1.04 | Prev Close | $15.46 |
| Employees | 265 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -233.72% - | SMA200 | -19.86% ($20.11) | Avg Volume(3M) | 2.56M | Price | $16.12 |
| IPO | 2015/3/5 | Option/Short | Yes/Yes | Trades | 20787 | Volume | 2,655,825 | Change | 4.27% |
뉴스 로딩 중...